Presentation GI2 2012 When To Give The Green Light For Human Studies: The Value Of Translational Research Presenter: Renu Virmani April 12, 2012
Presentation GI2 2012 Starting with the Idea: Defining the Unmet Needs Presenter: Martin B. Leon April 12, 2012
Presentation GI2 2012 How to Improve TAVR Safety? The Role of Ancillary Devices Presenter: Martin B. Leon April 12, 2012
Presentation Clinical Outcomes After TAVR Using Valve Academic Research Consortium Definitions Presenter: Philippe Genereux April 12, 2012
Presentation GI2 2012 What Technology Modifications Required for Bioabsorbable Scaffolds to Broaden Indications for USE Presenter: Ron Waksman April 12, 2012
Presentation GI2 2012 Bioabsorbable Scaffold: New and Evolving Designs Presenter: Alexandre Abizaid April 12, 2012
Presentation GI2 2012 Drug-Eluting Balloon: Clinical Evidence for In-Stent Restenosis Presenter: Marco V. Wainstein April 12, 2012
Presentation GI2 2012 New Agents and Prevention of Contrast Induced Nephropathy Presenter: George Dangas April 12, 2012
Presentation GI2 2012 The Controversy: DES vs DEB for In-Stent Restenosis Presenter: Pedro A. Lemos April 11, 2012
Presentation GI2 2012 TAVR: Current Guidelines and Future Studies to Expand Indications Presenter: Martin B. Leon April 11, 2012